Pharmaceutical - Markets & Marketing

Filter

Current filters:

Markets & Marketing

Popular Filters

1 to 25 of 1088 results

European prescribing trends for mCR prostate cancer

20-11-2014

Johnson & Johnson/AstraZeneca’s Zytiga (abiraterone acetate) is the clear agent of choice for second-line…

Astellas PharmaAstraZenecaBayerDendreonFranceGermanyItalyJohnson & JohnsonMarkets & MarketingMedivationOncologyPharmaceuticalProvengeSpainUKXofigoXtandiZytiga

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

19-11-2014

The Pharma Letter reports from the FT Global Pharmaceutical and Biotechnology Conference 2014.

FT Global PharmaceuticalMarkets & MarketingPharmaceuticalResearchUK

Stronger punishments for production and sale of fake drugs in China

18-11-2014

Chinese authorities will hand out harsher punishment for the production and sale of fake and substandard…

ChinaMarkets & MarketingPharmaceuticalProductionRegulation

Medicines Australia welcomes new trade agreement with China

18-11-2014

Australia yesterday signed the Free Trade Agreement with China, after nearly 10 years of negotiations,…

AustraliaChinaFinancialMarkets & MarketingPharmaceuticalPolitics

Pharma serialization: Is our industry on the brink of a mass extinction event?

Pharma serialization: Is our industry on the brink of a mass extinction event?

18-11-2014

Former AstraZeneca serialization expert, Ian Haynes asks whether the fact that many pharma companies…

Markets & MarketingPharmaceuticalProductionRegulation

Pharma companies can still improve access to medicines, report shows

Pharma companies can still improve access to medicines, report shows

17-11-2014

Top pharma companies are doing more to improve access to medicine in developing countries over the last…

GlaxoSmithKlineGlobalMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Dynamic growth of pharmaceutical sales to hospitals in Poland

Dynamic growth of pharmaceutical sales to hospitals in Poland

13-11-2014

The year 2013 was better for the Polish pharmaceutical distribution market than 2012, when wholesale…

Markets & MarketingPharmaceuticalPMRPolandPricing

Ukraine plans to ban drug imports from Russia

Ukraine plans to ban drug imports from Russia

13-11-2014

The Ukrainian government is considering imposing a ban on the import of drugs from Russia. This comes…

Markets & MarketingPharmaceuticalPoliticsRussiaUkraine

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

UK health system spends most on AbbVie's Humira overall, according to HSCIC data on prescribing habits

UK health system spends most on AbbVie's Humira overall, according to HSCIC data on prescribing habits

12-11-2014

The Health & Social Care Information Centre has published its report on the prescribing habits of the…

HumiraLucentisMarkets & MarketingNational Health ServicePharmaceuticalResearchUKUnited Kingdom

Global melanoma market set to reach $3.6 billion by 2020

12-11-2014

The global melanoma therapeutics market was valued at $1.3 billion in 2013 and will expand at a compound…

Bristol-Myers SquibbEuropeJapanKeytrudaMarkets & MarketingMerck & CoOncologyOpdivoPharmaceuticalUSAYervoy

Afaxys announces wider US availability of ella emergency contraceptive

12-11-2014

US drugmaker Afaxys Pharmaceuticals, a division of Afaxys Inc, has announced wider US availability of…

AfaxysellaHRA PharmaMarkets & MarketingPharmaceuticalReproductiveUSAWomen's Health

Biologics will complement statins in cholesterol treatment space, says GlobalData

Biologics will complement statins in cholesterol treatment space, says GlobalData

11-11-2014

Biologics will play an influential role in shaping the future of cardiovascular drug treatment, in particular…

alirocumabAmgenCardio-vascularevolocumabMarkets & MarketingPharmaceuticalRegeneronSanofiUSA

China and Taiwan seek to cooperate in pharmaceutical industry

China and Taiwan seek to cooperate in pharmaceutical industry

11-11-2014

Pharmaceutical companies from the Chinese mainland and Taiwan convened for the first forum on cross-strait…

ChinaMarkets & MarketingPharmaceuticalResearchTaiwan

India takes action on spurious and sub-standard drugs

India takes action on spurious and sub-standard drugs

10-11-2014

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals…

GenericsIndiaMarkets & MarketingPharmaceuticalPoliticsRegulation

ScinoPharm and Nanjing King-friend team up to market new drugs in China

ScinoPharm and Nanjing King-friend team up to market new drugs in China

10-11-2014

ScinoPharm Taiwan and China’s Nanjing King-friend Biochemical Pharmaceutical (NKF) announced today…

Cardio-vascularChinaMarkets & MarketingNanjing King-friend BiochemicalPharmaceuticalRegadenoson InjectionResearchScinoPharma Taiwan

Israel’s pharma market will grow to over $2.3 billion by 2020, report

05-11-2014

Israel’s pharmaceutical market value will increase from around $1.9 billion in 2013 to $2.34 billion…

IsraelMarkets & MarketingPharmaceuticalResearchTeva Pharmaceutcal Industries

AOP Orphan brings Thromboreductin to Russian market

04-11-2014

Austria-based rare diseases specialist AOP Orphan is expanding its sales area for Thromboreductin (anagrelide)…

AnagrelideAOP OrphanMarkets & MarketingPharmaceuticalRare diseasesRussiaThromboreductin

Bristol-Myers reveals access plan for hep C drug daclatasvir

03-11-2014

US Pharma major Bristol-Myers Squibb has recently revealed a commercial strategy for sales of its new…

Anti-viralsBristol-Myers SquibbdaclatasvirDaklinzaMarkets & MarketingPharmaceuticalPricing

Pharming and Salix's Ruconest launches in the USA for hereditary angioedema

Pharming and Salix's Ruconest launches in the USA for hereditary angioedema

03-11-2014

Pharming Group and Salix Pharmaceuticals have launched Ruconest (C1 esterase inhibitor) in the USA for…

Cardio-vascularMarkets & MarketingPharmaceuticalPharming Group NVRuconestSalixUSA

Novo Nordisk and Roche Diabetes Care launch new treatment option

Novo Nordisk and Roche Diabetes Care launch new treatment option

03-11-2014

Danish diabetes care giant Novo Nordisk has today launched NovoRapid PumpCart, the first pre-filled pump…

DiabetesMarkets & MarketingNovo NordiskNovoRapidPharmaceuticalRocheSwitzerland

India’s Cipla calls for revocation of Novartis’ Onbrez patents

01-11-2014

Indian drugmaker Cipla has asked the government to revoke five patents that Swiss pharma major Novartis…

CiplaIndiaMarkets & MarketingNovartisOnbrezPatentsPharmaceuticalRespiratory and PulmonaryUnibrez

Medivation and Astellas' Xtandi to be market-leader in prostate cancer by 2023

Medivation and Astellas' Xtandi to be market-leader in prostate cancer by 2023

31-10-2014

Xtandi (enzalutamide), produced by biopharma company Medivation and Japanese drug major Astellas Pharma…

AstellasDecision Resources GroupJohnson & JohnsonMarkets & MarketingMedivationOncologyPharmaceuticalXtandiZytiga

1 to 25 of 1088 results

Back to top